Tenofovir Disoproxil Fumarate Alone Versus Its Combination With Emtricitabine for Treatment of Chronic Hepatitis B
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Emtricitabine (Primary) ; Emtricitabine/tenofovir disoproxil fumarate (Primary) ; Tenofovir disoproxil fumarate (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 17 Feb 2017 Status changed from recruiting to discontinued.
- 26 Jan 2017 Planned primary completion date changed from 1 Jan 2017 to 4 Jan 2018.
- 05 Jan 2017 Planned End Date changed from 1 Jan 2019 to 1 Jan 2024.